UCP1 and metabolic syndrome: Considering the associations among psoriasis and dyslipidemia, inflammation, disease severity (as reflected by PASI scores), and cardiovascular disease, this study aimed to investigate the alterations in UCP1 level, as an important regulator of lipid metabolism, and to evaluate the potential role of these changes in the pathogenesis of psoriasis.